Vera Therapeutics Statistics
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.25+0.83 (+2.82%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Vera Therapeutics by the numbers
Vera Therapeutics has a market capitalization of $2.18 billion based on 72.06M shares outstanding. With trailing EPS of $-5.87, Vera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.9% below its 50-day average and 22.1% below its 200-day average.
Average daily trading volume is 2.21M shares, or about $66.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VERA valuation vs. peer median
| Metric | VERA | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.18B | $2.25B | -3% |
| Avg. volume | 2.21M | 1.10M | +101% |
Peer median across 8 companies: PHVS, AUPH, IMNM, PBH, SLS, VRDN, HRMY, BHC.
Valuation
- Market cap
- $2.18B
- EPS (TTM)
- $-5.87
- Shares outstanding
- 72.06M
Price and trading
- Previous close
- 29.42
- Open
- 29.09
- Day range
- 28.46 – 30.61
- 52-week range
- 23.05 – 56.05
- 52-week change
- -1.79%
- Beta
- —
- Volume
- 3.29M
- Average volume
- 2.21M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.18B
- Forward Pe
- -7.10
- Eps
- -5.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 56.05
- Week52 Low
- 23.05
- Avg Volume
- 2.21M
- Shares Outstanding
- 72.06M
- Ma50
- 32.85
- Ma200
- 38.83
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -46.03%
- Pct From52w Low
- 31.24%